Tipsheet
What matters at India’s listed companies
The Close / 27 Jul 2026 · 4:00 PM IST

Defence orders, governance red flags define the close

Sigma's artillery order, Cipla's Advair nod, CFO exits at Indus and Home First, and promoter sell-offs dominate.

Nifty 500 11,147.55 +0.70%
Nifty Midcap 150 7,757.15 +0.66%
Nifty Smallcap 250 5,861.60 +0.30%
Nifty Microcap 250 24,937.10 0.00%
Major NSE sectoral indices latest
IndexLevelMove
Bank Nifty 56,755.60 -0.58%
Nifty Auto 27,843.90 0.00%
Nifty Energy 38,174.80 0.00%
Nifty Financial Services 28,497.30 0.00%
Nifty FMCG 48,881.20 0.00%
Nifty Healthcare 16,497.70 0.00%
Nifty IT 30,418.35 +3.32%
Nifty Media 1,558.60 0.00%
Nifty Metal 12,400.25 0.00%
Nifty Pharma 25,998.85 +0.20%
Nifty Private Bank 16,648.10 +2.00%
Nifty PSU Bank 8,284.20 0.00%
Nifty Realty 921.45 0.00%
Nifty Cement 15,276.60 0.00%
Nifty Chemicals 30,047.25 0.00%
Nifty Consumer Durables 39,550.80 0.00%
Nifty Oil & Gas 11,067.85 0.00%
Market map
  • Large-cap pharma: Cipla's Advair approval is the standout, with broad US generic read-through.
  • Mid-cap defence: Sigma Advanced and BEL (concall) dominate order-book visibility.
  • Micro-cap governance: Prabhhans promoter exits, Pavna warrant lapses, and ACE EduTrend's 500% dilution are red flags.
  • CFO churn: Indus Towers and Home First both saw CFO departures, raising governance questions.
  • Chemical capex: Epigral and Supreme Petrochem commit large sums to expansion, but Epigral's strategy flip tests credibility.
By size
Mega cap 2 Other ₹2.20 L cr Mid cap 4 Order Wins / Other ₹47,963 cr Small cap 4 Other / Earnings ₹13,926 cr Micro cap 4 Other / Credit ₹1,006 cr
By sector
IT - Software 2 Mid cap / Small cap Chemicals 2 Mid cap / Small cap Pharmaceuticals 1 Mega cap Telecom 1 Mega cap Housing Finance 1 Mid cap Engineering - Industrial Equipments 1 Micro cap Cement 1 Micro cap Media & Entertainment 1 Micro cap
What moved today14
SIGMAADV Order Wins Mid cap IT - Software

Sigma Advanced Systems Ltd.

Sigma Advanced Systems locked in a $104.9 million artillery export order, more than double its FY26 revenue of ₹492 crore. This single contract validates its pivot from aerospace components to defence manufacturing and transforms near-term visibility. For a mid-cap stock trading at 40x trailing earnings, the order lifts the floor on revenue but raises the bar on execution. The open question is whether margins on this order meet the 25%+ that the stock prices in.

₹1,013 cr
Export order size, more than
₹10,840 cr
Mid cap mcap
40.44x
P/E
+608.6%
PAT
+469%
Rev
0.96x
D/E
1-week price +8.10% · 1wk
Read the note
CIPLA Other Mega cap Pharmaceuticals

Cipla Ltd.

Cipla won US FDA approval for its generic version of Advair Diskus, a $908 million US market for asthma and COPD. This is exactly the kind of high-value, complex respiratory launch Cipla needs to rebuild its US business after Revlimid erosion. The approval validates its New York facility and DPI strategy. Impact depends on launch timing, pricing, and market share, but the regulatory hurdle is cleared.

$908 million
Total US market for Advair Diskus
₹1.16 L cr
Mega cap mcap
29.99x
P/E
-55.09%
PAT
-2.8%
Rev
0.01x
D/E
Read the note
INDUSTOWER Other Mega cap Telecom

Indus Towers Ltd.

Indus Towers' CFO resigned, but the company disclosed it only after a two-month delay at a ₹1 trillion market-cap company. That erodes trust in governance even as operating metrics hold steady. For a stock reliant on Vodafone Idea exposure and an Africa pivot, the disclosure lapse adds an avoidable risk premium.

₹1 trillion
Mkt cap of Indus Towers amid
₹1.04 L cr
Mega cap mcap
14.53x
P/E
+0.78%
PAT
+4.84%
Rev
0.07x
D/E
Read the note
HOMEFIRST Other Mid cap Housing Finance

Home First Finance Company India Ltd.

Home First Finance's CFO exits even as Q1 profit jumped 34.5% to ₹160 crore. In a regulated financial firm, an unexplained CFO departure injects uncertainty. The strong quarter provides a buffer, but the stock's 23x P/E rewards consistency, and leadership gaps test that.

₹160 cr
Q1 FY27 PAT, up 34.5% YoY
₹12,456 cr
Mid cap mcap
23.05x
P/E
+42.75%
PAT
+20.92%
Rev
2.43x
D/E
Read the note
PAVNAIND Credit Micro cap Engineering - Industrial Equipments

Pavna Industries Ltd.

Pavna Industries keeps ₹30.3 crore after promoters let their warrant subscription lapse, a sum equal to 12.8% of its market cap. The cash retention is a windfall for existing shareholders, but the lapsed capital raise signals that promoters were either unwilling or unable to put in the ₹90.9 crore needed. For a nano-cap with a 3.7% ROE, that undermines the growth story.

₹30.30 cr
Forfeited upfront warrant
₹246 cr
Micro cap mcap
53.39x
P/E
+32.47%
PAT
-17.78%
Rev
0.18x
D/E
1-week price +4.03% · 1wk
Read the note
ACEEDU Other Micro cap Media & Entertainment

ACE EduTrend Ltd.

ACE EduTrend, a nano-cap with a ₹4 crore market cap and zero revenue, plans a ₹50 crore rights issue that would dilute existing holders by over 500%. If executed, it represents a dramatic transformation or a desperate gamble. The extreme dilution signals that management sees no value in the current structure.

₹50 cr
Proposed rights issue size
₹4.08 cr
Micro cap mcap
-7.14%
PAT
0x
D/E
1-week price +12.66% · 1wk
Read the note
PRABHHANS Other Micro cap Trading

Prabhhans Industries Ltd.

Prabhhans Industries' managing director sold 11.6% of the company in two days, reducing his stake to 25.3%. This follows a full exit by another promoter last month. For a ₹24 crore nano-cap, the insider base is hollowing out, a clear vote of no confidence from those closest to the business.

11.6 percentage points
Stake reduction by promoter MD in
₹23.84 cr
Micro cap mcap
14.56x
P/E
-36.28%
PAT
+1.28%
Rev
0.7x
D/E
1-week price +4.36% · 1wk
Read the note
AURIONPRO Earnings Small cap IT - Software

Aurionpro Solutions Ltd.

Aurionpro Solutions landed a $33 million three-year US contract, its largest ever, representing roughly 19% of FY26 revenue. Though Q1 was soft on supply-chain headwinds, the order book now supports management's guidance for accelerating H2 growth. The US fintech expansion is the real growth lever ahead.

USD 33M
Three-year US contract —
₹4,946 cr
Small cap mcap
23.63x
P/E
+21.48%
PAT
+5.69%
Rev
0.01x
D/E
Read the note
VSSL Other Small cap Steel & Iron Products

Vardhman Special Steels Ltd.

Vardhman Special Steels committed ₹1,116 crore for a forging unit, up from a ₹475 crore plan, or 38% of its market cap. The partnership with Aichi Steel adds technology credibility, but the scale is the real surprise. Analysts will need to rework capex and earnings models for this small-cap steel maker.

₹1,116 cr
Total investment across two
₹2,735 cr
Small cap mcap
29.38x
P/E
+72.2%
PAT
+6.98%
Rev
0.15x
D/E
1-week price -3.85% · 1wk
Read the note
EPIGRAL Other Small cap Chemicals

Epigral Ltd.

Epigral approved a ₹600 crore epoxy resin plant, 12% of its market cap, shifting into higher-value epoxy resins. This is a strategic pivot from caustic soda into renewable energy and electronics inputs. But the move contradicts management's January statement that it had no plan to enter epoxy, a credibility gap that investors will weigh.

₹600 crore
Capex for epoxy resin plant, 12%
₹4,772 cr
Small cap mcap
14.38x
P/E
-5.41%
PAT
+17.29%
Rev
0.25x
D/E
Read the note
SPLPETRO Other Mid cap Chemicals

Supreme Petrochem Ltd.

Supreme Petrochem's Q1 net profit more than doubled to ₹236 crore, and the board cleared a ₹325 crore expansion funded from internal accruals. The expansion preserves its zero-debt balance sheet but won't complete until 2029. The profit surge reflects strong demand from appliances and exports, but the payoff is years away.

₹236.3 cr
Q1 standalone net profit, more
₹14,019 cr
Mid cap mcap
42.58x
P/E
+57.83%
PAT
+4.33%
Rev
0x
D/E
1-week price +7.49% · 1wk
Read the note
WAAREERTL Order Wins Mid cap Power Generation

Waaree Renewable Technologies Ltd.

Waaree Renewable Technologies bagged 1,082 MWp of solar EPC orders, adding to its existing 2.83 GW portfolio. While the value is undisclosed, the scale is material for a mid-cap with a ₹10,648 crore market cap. Low debt and a strong execution track record support delivery, deepening ties with large developers.

1,082 MWp
Capacity of new solar EPC orders
₹10,648 cr
Mid cap mcap
22.24x
P/E
+66.06%
PAT
+131.31%
Rev
0.06x
D/E
1-week price -6.80% · 1wk
Read the note
RAJESH Order Wins Small cap Engineering - Construction

Rajesh Power Services Ltd.

Rajesh Power Services won a ₹75 crore substation order from Rajasthan's state utility, adding to its ₹3,742 crore order book. At 4.6% of FY26 revenue, the order provides near-term visibility and demonstrates repeat business. The company's strong balance sheet with a debt-to-equity of 0.21 supports execution across new states.

₹75.05 cr
New turnkey order from Rajasthan
₹1,473 cr
Small cap mcap
10.29x
P/E
35.44%
ROE
0.21x
D/E
1-week price -1.85% · 1wk
Read the note
Management changed its story
  • Northern ARC Capital softened its FY27 ROA target from 3.2% to 'closer to 3%' without explanation. Credit cost guidance was also revised downward, and MFI protection coverage changed from 84% under CGFMU to roughly 94% under CGTMSE without reconciliation. The guidance shifts undermine credibility despite strong Q1 numbers.

    NORTHARC concall note
  • Senores Pharmaceuticals cut its branded generics revenue target for FY27 to ₹50-60 crore from the earlier ₹80-100 crore, attributing it to a profitability-first strategy. The prior projections were not reconciled. The guidance flip creates dissonance against a strong pipeline and 30% EBITDA margin.

    SENORES concall note
  • Epigral's management told investors in January it had no plan to enter epoxy. In July, it announced board approval for a ₹600 crore epoxy plant. The company also reversed its view on India's caustic soda trade balance without explanation. The strategy whiplash makes future guidance harder to trust.

    EPIGRAL concall note
From the calls
  • Zen Technologies lowered its FY27 year-end order book target to ₹2,500 crore from ₹3,000 crore guided in May, without explaining the ₹500 crore reduction. The company's Q1 revenue fell 10.5% YoY and EBITDA margin missed the 35% target. The guidance slide, combined with execution dependency on government procurement conversion, tests credibility.

    ZENTEC concall note
  • Bharat Electronics' QRSAM order now expected by September 2026, the third timeline shift from prior guidance of March 2026. Management maintained its FY27 revenue growth target of 15% and order inflows above ₹55,000 crore, but QRSAM's persistent delay adds execution risk. AMCA RFP has also slipped, creating near-term order uncertainty.

    BEL concall note
  • Mold-tek Packaging's management said in May that lube volumes had stabilised; in July, they reported a 17% decline due to base oil unavailability at private customers. FY27 capex guidance also rose to ₹90 crore from ₹80-85 crore without explanation, and a new plant was repurposed from pharma to medical devices. Record EBITDA per kg of ₹46.7 is overshadowed by these confusing signals.

    MOLDTKPAC concall note
  • Share India raised its PMS AUM target from ₹200 crore to ₹250 crore, changed the MTF target from ₹650 crore in FY27 to ₹1,000 crore over two years, and shortened branch breakeven timelines, all without explaining the revisions. The guidance shifts create credibility concerns even as standalone PAT grew 32%.

    SHAREINDIA concall note
Tomorrow
  • IN · Railway Freight · impact L
  • IN · Corporate Bond Issuance · prev -32.64 YoY% · impact M